6. Insulet Corporation (NASDAQ:PODD)
Price Target Upside: 81.99%
Insulet Corporation (NASDAQ:PODD) is among the best 52-week low stocks to invest in.
TheFly reported on April 7 that Citigroup lowered PODD from Buy to Neutral and reduced its price target to $230 from $338 ahead of the company’s first-quarter results. The downgrade was driven by concerns over rising competition in the patch pump market. The firm also indicated that upcoming rival devices expected to enter the market in 2027 could limit the stock’s ability to outperform going forward.
Additionally, on March 30, Insulet Corporation (NASDAQ:PODD) appointed Mike Panos as Executive Vice President and Chief Commercial Officer, effective immediately. In this role, he will oversee the company’s global commercial operations and report directly to President and CEO Ashley McEvoy, while also joining the executive leadership team. The company highlighted that the appointment supports its strategy to expand adoption of its Omnipod platform and strengthen execution across international markets. Management emphasized growth opportunities driven by clinical performance, patient-focused innovation, and broader use of automated insulin delivery in both type 1 and type 2 diabetes.
Panos brings around 30 years of experience in medical technology sales leadership, including senior roles at Stryker Corporation, such as leading major divisions and overseeing North American and global commercial functions. His background includes building large-scale sales organizations, expanding market reach, and driving consistent revenue growth. PODD expects his expertise to enhance commercial discipline, support expansion into new patient groups, and accelerate overall global growth initiatives.
Insulet Corporation (NASDAQ:PODD) is a medical device company focused on insulin delivery systems for people with diabetes. It is best known for its Omnipod tubeless insulin pump, which provides continuous insulin therapy through a wearable, automated system designed to simplify diabetes management.
While we acknowledge the potential of PODD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PODD and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Best Beaten Down Stocks to Invest in According to Analysts.
Disclosure: None. Follow Insider Monkey on Google News.
